Evidence map›Paper›PMID 33660148›Full record

ArticleMedical oncology (Northwood, London, England)2021

Protein interacting with C-kinase 1 is involved in epithelial-mesenchymal transformation and suppresses progress of gastric cancer.

Ying Zhou, Kaiqiang Li, Yaoqiang Du, Zhaoyu Wu, Hao Wang, Xin Zhang, Yexiaoqing Yang, Linjie Chen, Ke Hao, Zhen Wang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ying Zhou *Research Center of Blood Transfusion Medicine, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
Kaiqiang Li *Research Center of Blood Transfusion Medicine, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
Yaoqiang Du *Research Center of Blood Transfusion Medicine, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
Zhaoyu WuSchool of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
Hao WangSchool of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
Xin ZhangDepartment of Pathology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
Yexiaoqing YangSchool of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
Linjie ChenSchool of Laboratory Medicine, Hangzhou Medical College, Hangzhou, 310053, China.
Ke HaoResearch Center of Blood Transfusion Medicine, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.
Zhen WangResearch Center of Blood Transfusion Medicine, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China. wangzhen@hmc.edu.cn.ORCID http://orcid.org/0000-0002-8581-4649
Jianxin LyuSchool of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, China. jxlu313@163.com.
Wenzhou Medical University · CNZhejiang Provincial People's Hospital · CNHangzhou Medical College · CN

Funding

Medicine and Health Research Foundation of Zhejiang Province 2019KY017Medicine and Health Research Foundation of Zhejiang Province 2019RC012Medicine and Health Research Foundation of Zhejiang Province WKJ-ZJ-2019National Natural Science Foundation of China 81772664National Natural Science Foundation of China 81830071Natural Science Foundation of Zhejiang Province LQ21H200007Traditional Chinese Medicine Scientific Research Foundation of Zhejiang Province 2018ZY001
6 · The paper itself

Abstract

Protein interacting with C-kinase 1 (PICK1) is a 415-aa multidomain scaffold protein encoded by the PICK1 gene. Accumulating evidence suggests that PICK1 is involved in the progression of cancer. However, the role of PICK1 in gastric cancer (GC) remains largely unknown. Using integrated analysis of publicly available GC transcriptome data from the Gene Expression Omnibus (GEO) database and immunohistochemistry analysis of samples obtained from clinical GC patients, we found that PICK1 expression was significantly down-regulated in gastric tumor tissues in comparison with adjacent normal tissues. Our analyses also revealed that decreased expression of PICK1 conferred a disadvantage on overall survival time in GC patients. Additionally, PICK1 expression showed a strong association with the epithelial-mesenchymal transition (EMT) pathway, and PICK1 might represent a functional bridge for EMT. Moreover, PICK1 expression was significantly decreased in the EMT subtype of GC and was negatively correlated with the expression of fibronectin 1 (FN1) and myosin light chain 9 (MYL9) mRNAs. Thus, our study provides evidence that PICK1 is a promising biomarker for the molecular etiology of GC.

Indexed as

Epithelial-Mesenchymal TransitionBiomarkers, TumorCarrier ProteinsCell Line, TumorDown-RegulationFibronectinsGene ExpressionHumansMyosin Light ChainsNuclear ProteinsPrognosisProtein Interaction MapsStomach NeoplasmsBiomarkers, TumorCarrier ProteinsFibronectinsFN1 protein, humanMYL9 protein, humanMyosin Light ChainsNuclear ProteinsPICk1 protein, humanEpithelial-mesenchymal transitionGastric cancerPICK1Prognosis

Identifiers

PMID33660148
OpenAlexW3135268780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.